Tuesday, December 30, 2008
Transgene Biotek inks pact with Heber Biotec
Transgene Biotek announced that it has entered into a commercial and development agreement with Heber Biotec S.A, Havana, Cuba for the development and commercialization of three vaccines, Hib conjugate vaccine, DPT+Hib quadrivalent combination vaccine, DPT+Hib+Hepatitis B pentavalent vaccine
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment